Brent Ahrens on venture capital funding for biotech companies

Ahrens, general partner with Canaan Partners discusses the session he is organizing, “Wait! Our Model Isn’t Dead! We Just Need to Evolve,” general trends and issues in venture capital financing in biotech, and the impact of the IPO market on venture and private equity firms.